Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034186 (
pyelonephritis
)
6,144
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Urinary cyclic
AMP
excretion per 24 h or per g creatinine in primary hyperparathyroidism (1 degrees HPT) has been evaluated by several authors with conflicting results. In 50 patients with 1 degrees HPT, 25 patients with secondary (2 degrees) HPT and 35 healthy control persons we determined urinary cyclic
AMP
per 24 h or per g creatinine. These parameters did not satisfactorily discriminate patients from controls, especially when glomerular filtration rate (GFR) as determined by creatinine clearance was reduced. Since urinary cyclic
AMP
is derived from plasma by glomerular filtration and from kidney by tubular production-the amount of tubules is reflected by GFR-the cyclic nucleotide was related to GFR. In controls urinary cyclic
AMP
correlated better with GFR than with creatinine excretion. Additionally, in 45 of 50 patients with 1 degrees HPT and in all with 2 degrees HPT, urinary cyclic
AMP
/GFR was raised. In 1 degrees HPT serum levels of parathyroid hormone correlated closer with urinary cyclic
AMP
/GFR than with urinary cyclic
AMP
/g creatinine. The ratio cyclic
AMP
/GFR decreased to normal or subnormal values after removal of adenomatous or hyperplastic glands in 1 degrees HPT and during infusion of calcium in 2 degrees HPT. In 50 patients with renal lithiasis caused by diseases other than 1 degrees HPT (anatomical variations,
pyelonephritis
, immobilization after tetraplegia) the ratio cyclic
AMP
/GFR was not raised. Urinary cyclic
AMP
/GFR, therefore, reflects parathyroid hormone excess more reliably than cyclic
AMP
/g creatinine.
...
PMID:Hyperparathyoidism: influence of glomerular filtration rate on urinary excretion of cyclic AMP. 19 82
Twenty-five children (16 females and 9 males) aged from 8 months to 10 years with clinical and laboratory evidence of UTI were treated with sulbactam + ampicillin (SBT/
AMP
). Twenty-four of them were suffering from cystitis and one from
pyelonephritis
. Four of them were treated unsuccessfully prior to entry in the trial. The mean final dose of SBT/
AMP
was 47.69 mg/kg/die (ratio of SBT-
AMP
was 1:2). The patients were treated for 3 to 8 days (mean: 4.76 days). 84% were treated by i.m. route. No side effects or adverse experience were reported. Clinical cure was achieved in 25 patients (100%).
...
PMID:Clinical evaluation of sulbactam + ampicillin in the treatment of pediatric urinary tract infections. 321 51